Rahul Singhvi
 Rahul Singhvi    | |
|---|---|
 | |
| Nationality | Indian, US? |
| Alma mater | ITT Kanpur, MIT, Wharton School |
| Member of | National Resilience, Novavax |
cofounder and CEO of the spooky biomanufacturing company National Resilience, Inc., which produced the mRNA for hundred of millions of Moderna Covid jabs | |
Rahul Singhvi is a cofounder and CEO of the spooky biomanufacturing company National Resilience, Inc., which produced the mRNA for hundred of millions of Moderna Covid jabs.[1] He was previously with Takeda Pharmaceuticals and Novavax.[2]
If everybody got the vaccine
In November 2022, he implied that his product stopped "Covid variants" and told how National Resilience was building satellite plants around the world to jab everyone faster next time:
The important thing that we recognize was that same technologies that you need to make vaccines are the technologies that you need to address the problems of manufacturing for the new modality medicines that were emerging with the explosive unraveling of genomic data and the the development of new curative therapies like cell therapies, gene therapies, gene editing....As you all know nobody is safe unless everybody is safe, we knew this from this pandemic where people who haven't gotten vaccines have resulted in not only incredible amount of casualties but also the emergence of variants as this virus has replicated and created different types of versions and and we are just chasing those variants. If everybody got the vaccine, boom you're done hurting immunity, it is over, no more variants...How we want to do this is by creating satellites of National Resilience in different parts of the world. Every satellite has can be empowered with the power of the central node which is in the United States so instantaneously if you build a facility for example in this part of the world they can get the the power of what's happening in the US[3]
Education
Singhvi graduated as the top ranked chemical engineer from IIT, Kanpur, India and obtained further chemical engineering degrees from MIT. He received an MBA from the Wharton School of the University of Pennsylvania.[4]
Activities
Singhvi's professional career began at Merck & Co in 1994, where he held several positions in R&D and manufacturing.[4]
He was the Chief Operating Officer at Takeda's Vaccine Business Unit where he was responsible for global vaccine operations. During his six-year tenure at Takeda, "the vaccine business grew to over 500 employees and created an impressive late stage pipeline of vaccine candidates against dengue, norovirus, and zika."[4]
Under Rahul’s leadership, Novavax transformed from a failed specialty pharmaceutical business to a vaccine development company with vaccine candidates against influenza, thanks to funding by the deep state BARDA.[4]
He was Operating Partner at Flagship Pioneering, a Boston-based life sciences innovation firm where he was responsible for founding and operating companies launched from Flagship's innovation foundry, Flagship labs.
He became cofounder and CEO of the spooky biomanufacturing company National Resilience, Inc. in 2020, that produced the mRNA for the Moderna Covid jabs.
